Key result
Peripartum cardiomyopathy has an estimated incidence of 1 in 2,230 births in the United States and is associated with mortality rates ranging from 3% to 40% depending on geographic location.
Why the study?
Peripartum cardiomyopathy is an important and increasing cause of pregnancy-associated morbidity and mortality with an elusive etiopathogenesis, variable recovery and mortality rates, and no disease-specific therapies.
Design
Review
Authors
Loading...
PPCM incidence is rising with major morbidity; review leaves open etiology and management questions for targeted research.
This review summarizes the etiopathogenesis, clinical recognition, and evidence-based management of peripartum cardiomyopathy, highlighting its variable recovery and mortality rates.
Cunningham et al. (2019) conducted a review in Peripartum Cardiomyopathy. Peripartum cardiomyopathy has an estimated incidence of 1 in 2,230 births in the United States and is associated with mortality rates ranging from 3% to 40% depending on geographic location.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: